Skip to content

A randomised controlled study of sublingual versus vaginal misoprostol for pre induction cervical ripening at term in ESUT Teaching Hospital, Parklane, Enugu

A randomised controlled study of sublingual versus vaginal misoprostol for pre induction cervical ripening at term

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202412607511645
Enrollment
108
Registered
2024-12-02
Start date
2024-12-05
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth

Interventions

vaginal misoprostol group
Sublingual misoprostol group

Sponsors

Dr Innocent Onyemechi Obeta
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: nulliparous women singleton pregnancies cephalic presentation gestational ages between 37 weeks to 42 weeks medical or obstetric indication for induction of labour no contra-indication to vaginal delivery.

Exclusion criteria

Exclusion criteria: multiparity, previous uterine scar, abnormal presentations, foetal macrosomia (= 4.0kg), oligohydramnios, polyhydramnios, intra-uterine growth restriction, diabetes mellitus in pregnancy, foetal anomalies, cephalopelvic disproportion, patients with known hypersensitivity or contraindications to use of prostaglandins such as asthma.

Design outcomes

Primary

MeasureTime frame
The primary outcome measure will be the induction to vaginal delivery interval

Secondary

MeasureTime frame
The secondary outcome measures will be: 1. The route of delivery 2. Number of misoprostol doses needed to achieve active phase labour 3. The need for oxytocin augmentation of labour 4. Number of women with hyperstimulation 5. Number of women with failed cervical ripening 6. Number of women with failure to progress to active phase 7. Number of women with failure to progress to second stage 8. Number of caesarean section due to failed induction 9. Number of caesarean section due to fetal distress 10. Number of babies with NICU admission 11. Maternal satisfaction with particular route of administration of misoprostol

Countries

Nigeria

Contacts

Public ContactIfeanyichukwu Ofor

Lecturer 1

ofor.ifeanyi@gmail.com+2348037546411

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026